An underground market for unlicensed weight-loss drugs is being driven by TikTok fitness influencers and sellers on communication apps, based on new investigations.
Experimental Treatment Gaining Popularity Online
Retatrutide, which remains in research studies, is being promoted by social media influencers for its alleged fat-burning properties. Followers are encouraged to message these accounts directly for supplier links, while also obtaining discount codes.
Thriving Trade on Messaging Platforms
Additionally, a flourishing market exists on Telegram, where communities with numerous of participants share “before and after” photos, injection guides and claims of next-day UK delivery. Vendors promote the substance there before directing buyers to WhatsApp for transactions.
Understanding Retatrutide
Retatrutide is an experimental injectable developed by US drugmaker Eli Lilly. The treatment affects three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials indicate it could assist individuals reduce up to 25% of their body weight. Referred to as the “triple G”, the substance is being hailed online as the successor to Ozempic.
Healthcare Experts Voice Concerns
However, physicians and pharmacists have cautions that the sale of what is still an unapproved drug in the UK is worrisome and could lead to users administering products of unknown origin.
Some experts stated the demand for the experimental drug could be connected to the rising cost of approved slimming treatments such as Mounjaro.
Regulatory Position and Implementation
Marketing the unapproved drug on social media or messaging apps is prohibited in the United Kingdom, as it is an unlicensed medication that cannot be marketed or distributed for personal consumption under the British medical regulations.
Several content creators try to sidestep the rules by calling to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted substance, but promotion and supply can still breach medicines, marketing, and customer laws, risking fines, prosecution or imprisonment.
Platform Response and Material Removal
According to TikTok, the service has removed problematic content and prohibited associated hashtags and search suggestions. The organization stated it was committed to keeping the platform safe and investing in strengthening enforcement strategies.
Digital Marketplace Operations
Research also discovered communities with up to 9,000 members marketing the experimental drug using the platform's built-in discovery tool, which functions like a online catalog. Entering “retatrutide” immediately displays channels with thousands of members, filled with images of weight loss, glowing reviews and detailed instructions for preparing or injecting at home.
After minutes of joining one community, a seller shared WhatsApp details, where most purchases take place. The seller provided an instruction manual and guaranteed delivery within two days. When asked whether the product was genuine, one vendor said: “You can’t be sure.” Another shared a image of a alleged testing documentation. None inquired about body mass, medical conditions or previous experience.
Product Details and Costs
Within these communities, messages display dark colored packages with Royal Mail labels, stating to contain fresh supplies. One communication read: “It took eight of us to load them this morning.”
Buyers can choose between powder vials, mixed at home with sterile water, or ready-to-use pens usually priced at £160 for 20 milligrams. When questioned how much time a pen should be used, sellers give contradictory responses ranging from a several days to “depends on your body”.
Service Oversight and Security Actions
A representative for the messaging service stated it actively moderated harmful content on its platform including material that encouraged the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.
Healthcare Expert Warnings
“People are administering substances they can’t verify. Although the science behind this drug is valid, these online products may not include what they advertise,” said Jason Murphy, the head of pharmaceutical services at Chemist4U.
A medical professional of Asda Online Doctor connected the surge in interest to recent cost increases for authorized slimming drugs such as Mounjaro. “With prices increasing, individuals are turning to social media. But counterfeit treatments are extremely risky. You can’t be certain what’s inside or whether the conditions they were made in was sterile,” she said.
Her staff has already seen individuals injured by personal administration from unconfirmed sources. “We understand the disappointment, but purchasing from messaging apps or communication platforms is taking chances with your well-being,” stated the doctor. “These substances could be impure or improperly measured.”
Manufacturer Position
A representative from the pharmaceutical company stated the substance was in third stage research studies and had not been evaluated or authorized by any government authority anywhere in the world. “Therefore at this time no one can market [it] for human use,” they explained, noting that any item “falsely representing itself as a Lilly experimental product not yet approved … may expose users to possibly significant medical dangers”.
